Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-12

Clinical Trial Update: Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a beta-glucan assay in patients on voriconazole prophylaxis; results completed and posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VFEND (Voriconazole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Fungal Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-05-12